28 / PRNewswire / -- Decision Resources , one of the world 's leading research and advisory firms for pharmaceutical and healthcare issues , finds that Roche / Chugai 's Avastin is prescribed by the majority of surveyed oncologists for glioblastoma multiforme , non-small-cell lung cancer and breast cancer .